Public Example Baseline

Semaglutide: from high-risk comorbidity settings to general obesity weight management

Review of a metabolic claim that began in a high-risk comorbidity setting and is now being extended to general adult obesity weight management.

Start with one claim Back to reconstructions

Illustrative

POSITION Indication scope

CONTEXT Metabolic

UPDATED Illustrative: public sources only, no customer data

How far the indication moved

Population the trials studied Type 2 diabetes with cardiovascular or renal risk

Population the claim now reaches General adult obesity weight management

Where each claim stands

One row per claim. The claim the record has moved furthest past is first.

The claim Population it is used for Where it stands Why Record at cutoff What would move it

Semaglutide reduces major adverse cardiovascular events in adults with established cardiovascular disease and overweight or obesity. High-risk cardiovascular population (SELECT-like) Claim still holds Supported by a dedicated cardiovascular outcomes trial in the public record. Still holds New trial readouts or label changes that narrow or broaden the indicated population.

Semaglutide is appropriate for general adult weight management without comorbidity-based restriction. General adult obesity weight management Record moved past the claim Long-term outcomes evidence in lower-risk populations is less mature; payer and guideline positions vary by jurisdiction. Moved past the claim Local coverage determination, guideline update, or new population-specific outcome data.

Furthest moved first: Moved past the claim → Moving → Still holds → Withdrawn

Limits

Public sources only. A particular plan's coverage rules are out of scope for a public example.
Where a claim stands is read off the dated record. Nothing here is a forecast of what a payer or regulator will do about it.
The grid says what the public record supports today and what would have to publish before the claim could be carried to the wider population.

Compare GLP-1 coverage by indication, plan, and effective date. This example is a historical reconstruction, not a current policy directory or a registered coverage forecast.